Ameriprise’s Cellcom Israel, Ltd. CEL Stock Holding History

Ameriprise’s Portfolio CEL Stock Details CEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-304	Closed	-$4K	–	5689
2014 Q1	$4K	Buy	+304	New	+$3.92K	﹤0.01%	4867

Other funds holding CEL

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

QBFM

QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Ameriprise's CEL Position: Q2 2014 in Review

Ameriprise sold out of Cellcom Israel, Ltd. (CEL) in Q2 2014, closing a stake of 304 shares — an estimated $4K sold.

Ameriprise first reported a position in CEL in Q1 2014 and held it in 1 quarter. The position peaked at $4K in Q1 2014. 48 funds tracked by Wall St. Rank hold CEL as of Q2 2014.

Ameriprise reported no remaining Cellcom Israel, Ltd. position as of Q2 2014 after selling out during the quarter.
Ameriprise sold 304 Cellcom Israel, Ltd. shares in Q2 2014, an estimated $4K.
Ameriprise first reported a position in Cellcom Israel, Ltd. in Q1 2014 and held it in 1 quarter.
Ameriprise's Cellcom Israel, Ltd. position peaked at $4K in Q1 2014.
48 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q2 2014.

Based on Ameriprise's 13F filing for Q2 2014, filed 13 Aug 2014.